Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fisker

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Clinical Endocrinology|June 26, 1998
Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjectsJ O Jørgensen, N Vahl, T B Hansen, et al.
Clinical Endocrinology|September 27, 2003
The gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormonesB Bülow, B Ahrén, S Fisker, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 22, 1999
The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapyA M Rosenfalck, S Fisker, J Hilsted, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adultsA M Rosenfalck, S Maghsoudi, S Fisker, et al.
Metabolism: Clinical and Experimental|October 1, 1995
Fuel metabolism in growth hormone-deficient adultsJ O Jørgensen, N Møller, T Wolthers, et al.
European Journal of Clinical Investigation|December 31, 2009
Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obeseM F Bennetzen, T S Nielsen, S K Paulsen, et al.
Scientific Reports|September 20, 2017
The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureusSteen G Stahlhut, Abdulelah A Alqarzaee, Camilla Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatmentS Fisker, K Kristensen, A M Rosenfalck, et al.
European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Clinical Endocrinology|June 26, 1998
Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjectsJ O Jørgensen, N Vahl, T B Hansen, et al.
Clinical Endocrinology|September 27, 2003
The gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormonesB Bülow, B Ahrén, S Fisker, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 22, 1999
The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapyA M Rosenfalck, S Fisker, J Hilsted, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adultsA M Rosenfalck, S Maghsoudi, S Fisker, et al.
Metabolism: Clinical and Experimental|October 1, 1995
Fuel metabolism in growth hormone-deficient adultsJ O Jørgensen, N Møller, T Wolthers, et al.
European Journal of Clinical Investigation|December 31, 2009
Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obeseM F Bennetzen, T S Nielsen, S K Paulsen, et al.
Scientific Reports|September 20, 2017
The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureusSteen G Stahlhut, Abdulelah A Alqarzaee, Camilla Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatmentS Fisker, K Kristensen, A M Rosenfalck, et al.
European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.
Pageof 5